Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Working Capital/Sales

    Back to All Ratios
TRIDENT LIFELINE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

TRIDENT LIFELINE Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 2.361.410.847.03

What is the latest Working Capital/Sales ratio of TRIDENT LIFELINE ?

The latest Working Capital/Sales ratio of TRIDENT LIFELINE is 2.36 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.36
Mar20241.41
Mar20230.84
Mar20227.03

How is Working Capital/Sales of TRIDENT LIFELINE Trending?

Years Working Capital/Sales % Change
Mar2025 2.36
67.38
Mar2024 1.41
67.86
Mar2023 0.84
-88.05
Mar2022 7.03 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Working Capital/Sales ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹320.1 Cr 5.9% -11.5% -7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

5.9%

-11.5%

-7.2%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses